Physiomics PLC
17 November 2008
Physiomics plc
The Magdalen Centre
The Oxford Science Park
Robert Robinson Avenue
Oxford
OX4 4GA
UK
Tel 01865 784980
Fax 08701 671931
17 November 2008
Physiomics plc ("Physiomics" or "the Company")
Physiomics to present Physiomics' technology at the Bio-Europe Conference
Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it will be participating in the
2008 Bio-Europe 14th Annual International Partnering Conference, taking place at the Mannheim Congress Centre on 17-19 November 2008. Dr
Christophe Chassagnole, Chief Operating Officer of Physiomics, will give an update on the Company's activities and recent progress. The
presentation will be a part of the Enabling Technologies track, scheduled at 10:45 am on Wednesday 19 November.
More information about the conference may be found at www.ebdgroup.com/bioeurope
For further information:
Physiomics plc +44 (0)1865 784980
Dr Christophe Chassagnole, COO
E-mail: cchassagnole@physiomics-plc.com
Grant Thornton Corporate Finance +44 (0)20 7383 5100
Philip Secrett, Colin Aaronson
About Physiomics plc
Physiomics plc (AIM:PYC) is a computational systems biology services company applying simulations of cell behaviour to drug development
to reduce the high attrition rates of clinical trials. As 80-90 per cent of all clinical drug candidates fail to reach the market,
estimates1 show that an overall ten per cent improvement in success rates could reduce the cost of one drug's development by as much as $242
million, from the current estimate of around $800 million.
Physiomics develops computational systems biology models to predict and understand cancer drug efficacy from pre-clinical research to
clinical development. Physiomics has created detailed mathematical models incorporating most important molecular events taking place during
the human cell cycle and apoptosis processes. Physiomics developed SystemCellŽ technology, a multi-cellular environment software, which
enables the simulation of population of "virtual cells".
Physiomics, based in Oxford, UK, was founded in 2001, and floated on AIM in 2004. For further information, please visit
www.physiomics-plc.com
SystemCellŽ is a registered trademark of Physiomics plc
1Tufts Centre Impact Report 2002
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAFKQKBBBDDFDD
| 
